Tablets & Capsules


Issue link:

Contents of this Issue


Page 30 of 55

Tablets & Capsules March 2018 29 I and biosimilars. Despite this increasing use of parenteral drug delivery methods, solid oral dosage forms (SODFs) remain the most common drug delivery method, and the solid oral drug delivery market continues to grow. The FDA approval rate for SODFs has increased over the past several years. From 2015 to 2017, the FDA approved 39 tablets and 14 capsules, as shown in Table 1. Of the 45 drug products approved by the FDA in 2015, approximately 55 percent were SODFs. In 2017, half of This article looks at some important trends influencing the solid oral drug delivery market today and into the future. n recent years, parenterally delivered biologics have increasingly penetrated the pharmaceutical market due to their growing use in regenerative and personalized medicine as well as the development of new biologics Trends in the solid oral drug delivery market Awanish Kumar Pandey MarketsandMarkets Research market trends

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0318